Search Results - mark+yarmarkovich

1 Results Sort By:
Optimized discovery of tumor specific antigens for neuroblastoma immunotherapy
Data-driven discovery of tumor antigens using ligandomics, proteomics, and gene expressionMarket NeedThe current standard of care for high-risk neuroblastoma is extremely costly, involving an intense regimen of chemotherapy, radiation therapy, multiple surgeries, and immunotherapy (a typical treatment regimen for high-risk neuroblastoma can be found...
Published: 6/25/2019   |   Inventor(s): John Maris, Mark Yarmarkovich
Category(s): Therapeutic